242 related articles for article (PubMed ID: 3408455)
21. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
Horsti J
Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
[TBL] [Abstract][Full Text] [Related]
22. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
Loeliger EA; van den Besselaar AM; Lewis SM
Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
[TBL] [Abstract][Full Text] [Related]
23. Quality control and oral anticoagulation.
Preston FE
Thromb Haemost; 1995 Jul; 74(1):515-20. PubMed ID: 8578516
[TBL] [Abstract][Full Text] [Related]
24. [Control of the treatment with oral anticoagulants and prothrombin time].
Marzouka E
Rev Med Chil; 1991 Oct; 119(10):1160-4. PubMed ID: 1845211
[TBL] [Abstract][Full Text] [Related]
25. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
Mischke R
Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
[TBL] [Abstract][Full Text] [Related]
26. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids.
Bader R; Mannucci PM; Tripodi A; Hirsh J; Keller F; Solleder EM; Hawkins P; Peng M; Pelzer H; Teijidor LM
Thromb Haemost; 1994 Mar; 71(3):292-9. PubMed ID: 8029792
[TBL] [Abstract][Full Text] [Related]
27. International Committee for Standardization in Haematology/International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
Scand J Haematol; 1984 Oct; 33(4):397-8. PubMed ID: 6505637
[No Abstract] [Full Text] [Related]
28. Thromboplastin calibration. Experience of the Dutch reference laboratory for anticoagulant control.
Loeliger EA; van der Hoeff-van Halem R; van Halem-Visser LP
Thromb Haemost; 1978 Oct; 40(2):272-87. PubMed ID: 734632
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of the quality of prothrombin time technique in the Basque Country].
Vacas M; Lafuente PJ; Aguirrebeitia MJ; Iriarte JA
Sangre (Barc); 1998 Feb; 43(1):41-5. PubMed ID: 9577180
[TBL] [Abstract][Full Text] [Related]
30. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
[TBL] [Abstract][Full Text] [Related]
31. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
Loeliger EA; van Halem-Visser LP
Thromb Haemost; 1979 Dec; 42(4):1115-27. PubMed ID: 542924
[No Abstract] [Full Text] [Related]
32. Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
Greaves M;
Thromb Haemost; 2002 Jan; 87(1):163-4. PubMed ID: 11848446
[No Abstract] [Full Text] [Related]
33. Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.
Guglielmone HA; Vides MA
Ann Biol Clin (Paris); 1990; 48(8):547-50. PubMed ID: 2288441
[TBL] [Abstract][Full Text] [Related]
34. [Current biological surveillance of oral anticoagulant treatment].
Helft G; Vacheron A; Samama MM
Arch Mal Coeur Vaiss; 1995 Jan; 88(1):85-9. PubMed ID: 7646254
[TBL] [Abstract][Full Text] [Related]
35. [Recommendations of the ICSH/ICTH for expressing prothrombin time in the control of the temperature with oral anticoagulants].
Sangre (Barc); 1984; 29(6):1057-8. PubMed ID: 6533839
[No Abstract] [Full Text] [Related]
36. Recombinant tissue factor as substitute for conventional thromboplastin in the prothrombin time test.
Tripodi A; Arbini A; Chantarangkul V; Mannucci PM
Thromb Haemost; 1992 Jan; 67(1):42-5. PubMed ID: 1615481
[TBL] [Abstract][Full Text] [Related]
37. A comparison of INRs after local calibration of thromboplastin international sensitivity indexes.
McGlasson DL
Clin Lab Sci; 2002; 15(2):91-5. PubMed ID: 12776770
[TBL] [Abstract][Full Text] [Related]
38. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
Robert A; Chazouillères O
Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
[TBL] [Abstract][Full Text] [Related]
39. A high-sensitivity thromboplastin reagent prepared from cultured human cells.
Valdes-Camin R; Callahan JB; Ebert RF
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):617-24. PubMed ID: 7841320
[TBL] [Abstract][Full Text] [Related]
40. [Initial experiences with a recombinant human tissue thromboplastin in oral anticoagulation].
Vogt A; Woodhams B; Marbet GA
Schweiz Med Wochenschr; 1993 Jan; 123(3):74-6. PubMed ID: 8426950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
